Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

434
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
434
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.0K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

848
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
848
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

615
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
615
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

454
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
454
The Thyroid Gland01:23

The Thyroid Gland

6.8K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.8K
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 心血管医学と血液学
  5. 心臓病 (心血管疾患を含む)
  6. 甲状腺 と 心血管 疾患: 知識,予防,治療 の 向上 の ため の 研究 計画

甲状腺 と 心血管 疾患: 知識,予防,治療 の 向上 の ため の 研究 計画

Anne R Cappola1, Akshay S Desai2, Marco Medici3

  • 1Division of Endocrinology, Diabetes, and Metabolism, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (A.R.C.).

Circulation
|May 14, 2019

関連する実験動画

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.5K
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

953

PubMed で要約を見る

まとめ
この要約は機械生成です。

甲状腺機能障害は 複雑なメカニズムを通して 心血管の健康に影響します 将来の研究は,これらのリンクを理解し,バイオマーカーを特定し,より良い患者の結果のための標的治療を開発することに重点を置くべきです.

科学分野:

  • 心臓病科
  • 内分泌学
  • 分子生物学

背景:

  • 甲状腺ホルモンは心臓血管機能に大きな影響を与えます.
  • 心血管疾患の患者における甲状腺機能障害の分子メカニズムと最適な管理に関する知識のギャップが残っています.

研究 の 目的:

  • 心血管疾患の進行における甲状腺機能障害の役割を理解するための研究優先事項を確立する.
  • オミクスとビッグデータを含む研究機会と新しいアプローチを特定する.

主な方法:

  • 2017年9月に全国心臓,肺,血液研究所ワーキンググループを招集した.
  • 甲状腺の正常な生理学,機能不全の結果,心臓の電気生理学,血管系,心筋への治療効果について検討した.
  • 障壁や課題や将来の研究戦略について話し合った.

主要な成果:

  • 基礎生物学とバイオマーカー,標的治療のための患者のサブグループ識別,心血管疾患の臨床試験の3つの広範な研究分野を特定しました.
  • 心血管組織における甲状腺ホルモンの作用に関する新しいバイオマーカーの研究の必要性を強調した.
  • 特定の心血管疾患の予防および介入治療のための患者のサブグループを定義することを強調しました.

結論:

キーワード:
心拍不全,心臓発作動脈硬化症心不全甲状腺機能障害

関連する実験動画

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.5K
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

953
  • 甲状腺機能障害と心血管疾患を 関連付ける基礎生物学の研究が急務です
  • 甲状腺機能不全の患者の心血管疾患に対する標的型予防と介入戦略の開発は極めて重要です.
  • 甲状腺ホルモンの効果や 甲状腺刺激薬の効果を評価するために,臨床試験が必要である.
甲状腺機能低下
脂質